Pune, April 25, 2021 (GLOBE NEWSWIRE) -- Global Radiopharmaceutical Market 2021-2026:
Global “Radiopharmaceutical Market” is a comprehensive research that provides information regarding Radiopharmaceutical market size, trends, growth, cost structure, capacity, revenue, and forecast 2026. This report also includes the overall study of the Radiopharmaceutical Market share with all its aspects influencing the growth of the market. This report is an exhaustive quantitative analysis of the Radiopharmaceutical industry and provides data for making strategies to increase the Radiopharmaceutical market growth and effectiveness. The report further investigates and assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the Radiopharmaceutical market.
The global Radiopharmaceutical market size was USD 5865.4 million and it is expected to reach USD 10520 million by the end of 2026, with a CAGR of 8.6% during 2021-2026.
Get a sample copy of the report at - https://www.industryresearch.biz/enquiry/request-sample/15947540
Market Overview:
- Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
- In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
- The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
- Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.
To Understand How Covid-19 Impact Is Covered in This Report - https://www.industryresearch.biz/enquiry/request-covid19/15947540
Market Analysis and Insights: Global Radiopharmaceutical Market
- Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Radiopharmaceutical market in 2020.
- COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
- The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
- This report also analyses the impact of Coronavirus COVID-19 on the Radiopharmaceutical industry.
The major players in the market include:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
The report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
Enquire before purchasing this report - https://www.industryresearch.biz/enquiry/pre-order-enquiry/15947540
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including:
- Oncology
- Cardiology
- Other
Some of the key questions answered in this report:
- What will the market growth rate, growth momentum or acceleration market carries during the forecast period?
- Which are the key factors driving the Radiopharmaceutical market?
- What was the size of the emerging Radiopharmaceutical market by value in 2019?
- What will be the size of the emerging Radiopharmaceutical market in 2026?
- Which region is expected to hold the highest market share in the Radiopharmaceutical market?
- What trends, challenges and barriers will impact the development and sizing of the Global Radiopharmaceutical market?
- What are sales volume, revenue, and price analysis of top manufacturers of Radiopharmaceutical market?
- What are the Radiopharmaceutical market opportunities and threats faced by the vendors in the global Radiopharmaceutical Industry?
Global Radiopharmaceutical Market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and instrumentation and downstream demand analysis is additionally dispensed. The Global Radiopharmaceutical market development trends and marketing channels are analyzed. Finally, the feasibility of latest investment projects is assessed and overall analysis conclusions offered.
Purchase this report (Price 5900 USD for a single-user license) - https://www.industryresearch.biz/purchase/15947540
With tables and figures helping analyse worldwide Global Radiopharmaceutical market trends, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Some Points from TOC:
1 Study Coverage
1.1 Radiopharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceutical Market Size Growth Rate by Type
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Market Size Growth Rate by Application
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceutical Market Size Estimates and Forecasts
2.1.1 Global Radiopharmaceutical Revenue 2015-2026
2.1.2 Global Radiopharmaceutical Sales 2015-2026
2.2 Radiopharmaceutical Market Size by Region: 2020 Versus 2026
2.3 Radiopharmaceutical Sales by Region (2015-2026)
2.3.1 Global Radiopharmaceutical Sales by Region: 2015-2020
2.3.2 Global Radiopharmaceutical Sales Forecast by Region (2021-2026)
2.3.3 Global Radiopharmaceutical Sales Market Share by Region (2015-2026)
2.4 Radiopharmaceutical Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Radiopharmaceutical Revenue by Region: 2015-2020
2.4.2 Global Radiopharmaceutical Revenue Forecast by Region (2021-2026)
2.4.3 Global Radiopharmaceutical Revenue Market Share by Region (2015-2026)
3 Global Radiopharmaceutical by Manufacturers
3.1 Global Top Radiopharmaceutical Manufacturers by Sales
3.1.1 Global Radiopharmaceutical Sales by Manufacturer (2015-2020)
3.1.2 Global Radiopharmaceutical Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Radiopharmaceutical Manufacturers by Revenue
3.2.1 Global Radiopharmaceutical Revenue by Manufacturer (2015-2020)
3.2.2 Global Radiopharmaceutical Revenue Share by Manufacturer (2015-2020)
3.3 Global Radiopharmaceutical Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Radiopharmaceutical Manufacturers Covered: Ranking by Revenue
3.4.2 Global Radiopharmaceutical Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Radiopharmaceutical Manufacturing Base Distribution, Product Type
3.5.1 Radiopharmaceutical Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Radiopharmaceutical Product Type
3.5.3 Date of International Manufacturers Enter into Radiopharmaceutical Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bracco Imaging
4.1.1 Bracco Imaging Corporation Information
4.1.2 Bracco Imaging Description, Business Overview
4.1.3 Bracco Imaging Radiopharmaceutical Products Offered
4.1.4 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Bracco Imaging Radiopharmaceutical Revenue by Product
4.1.6 Bracco Imaging Radiopharmaceutical Revenue by Application
4.1.7 Bracco Imaging Radiopharmaceutical Revenue by Geographic Area
4.1.8 Bracco Imaging Radiopharmaceutical Revenue by Sales Channel
4.1.9 Bracco Imaging Recent Development
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Radiopharmaceutical Products Offered
4.2.4 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Bayer Radiopharmaceutical Revenue by Product
4.2.6 Bayer Radiopharmaceutical Revenue by Application
4.2.7 Bayer Radiopharmaceutical Revenue by Geographic Area
4.2.8 Bayer Radiopharmaceutical Revenue by Sales Channel
4.2.9 Bayer Recent Development
4.3 Mallinckrodt
4.3.1 Mallinckrodt Corporation Information
4.3.2 Mallinckrodt Description, Business Overview
4.3.3 Mallinckrodt Radiopharmaceutical Products Offered
4.3.4 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Mallinckrodt Radiopharmaceutical Revenue by Product
4.3.6 Mallinckrodt Radiopharmaceutical Revenue by Application
4.3.7 Mallinckrodt Radiopharmaceutical Revenue by Geographic Area
4.3.8 Mallinckrodt Radiopharmaceutical Revenue by Sales Channel
4.3.9 Mallinckrodt Recent Development
4.4 Nordion
4.4.1 Nordion Corporation Information
4.4.2 Nordion Description, Business Overview
4.4.3 Nordion Radiopharmaceutical Products Offered
4.4.4 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Nordion Radiopharmaceutical Revenue by Product
4.4.6 Nordion Radiopharmaceutical Revenue by Application
4.4.7 Nordion Radiopharmaceutical Revenue by Geographic Area
4.4.8 Nordion Radiopharmaceutical Revenue by Sales Channel
4.4.9 Nordion Recent Development
4.5 Triad Isotopes
4.5.1 Triad Isotopes Corporation Information
4.5.2 Triad Isotopes Description, Business Overview
4.5.3 Triad Isotopes Radiopharmaceutical Products Offered
4.5.4 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Triad Isotopes Radiopharmaceutical Revenue by Product
4.5.6 Triad Isotopes Radiopharmaceutical Revenue by Application
4.5.7 Triad Isotopes Radiopharmaceutical Revenue by Geographic Area
4.5.8 Triad Isotopes Radiopharmaceutical Revenue by Sales Channel
4.5.9 Triad Isotopes Recent Development
4.6 Lantheus
4.6.1 Lantheus Corporation Information
4.6.2 Lantheus Description, Business Overview
4.6.3 Lantheus Radiopharmaceutical Products Offered
4.6.4 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Lantheus Radiopharmaceutical Revenue by Product
4.6.6 Lantheus Radiopharmaceutical Revenue by Application
4.6.7 Lantheus Radiopharmaceutical Revenue by Geographic Area
4.6.8 Lantheus Recent Development
4.7 IBA Group
4.7.1 IBA Group Corporation Information
4.7.2 IBA Group Description, Business Overview
4.7.3 IBA Group Radiopharmaceutical Products Offered
4.7.4 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
4.7.5 IBA Group Radiopharmaceutical Revenue by Product
4.7.6 IBA Group Radiopharmaceutical Revenue by Application
4.7.7 IBA Group Radiopharmaceutical Revenue by Geographic Area
4.7.8 IBA Group Recent Development
Continued………….
Detailed TOC of Global Radiopharmaceutical Market @ https://www.industryresearch.biz/TOC/15947540
About Us:
Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors. Industry Research is the credible source for gaining the market reports that will provide you with the lead your business needs.